Spots Global Cancer Trial Database for hydromorphone
Every month we try and update this database with for hydromorphone cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain | NCT04296305 | Hematopoietic a... Malignant Solid... | Hydromorphone Placebo Adminis... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer | NCT03579446 | Hematopoietic a... Malignant Solid... Metastatic Mali... | Hydrocodone Hydromorphone Levorphanol Morphine Oxycodone Oxymorphone Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| NSAID Use After Robotic Partial Nephrectomy | NCT05842044 | Kidney Cancer Renal Cancer Renal Neoplasm | Ketorolac Acetaminophen Oxycodone Hydromorphone Ibuprofen | 18 Years - 99 Years | University of Miami | |
| Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies | NCT04258631 | Malignant Femal... | Hydromorphone Laparotomy Liposomal Bupiv... Questionnaire A... | 18 Years - 80 Years | Mayo Clinic | |
| The Effect of Esketamine on Patients Undergoing Tumor Surgery | NCT04613869 | Tumor Surgery | High-dose Esket... Low-dose Esketa... Hydromorphone | 18 Years - 65 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer | NCT03579446 | Hematopoietic a... Malignant Solid... Metastatic Mali... | Hydrocodone Hydromorphone Levorphanol Morphine Oxycodone Oxymorphone Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center | |
| The Effect of Esketamine on Patients Undergoing Tumor Surgery | NCT04613869 | Tumor Surgery | High-dose Esket... Low-dose Esketa... Hydromorphone | 18 Years - 65 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain | NCT03375515 | Cancer Pain | Hydromorphone PCA pump | 18 Years - 70 Years | Fujian Cancer Hospital | |
| Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients | NCT01621100 | Cancer Pain | OROS hydromorph... | 20 Years - | Janssen Korea, Ltd., Korea | |
| NSAID Use After Robotic Partial Nephrectomy | NCT05842044 | Kidney Cancer Renal Cancer Renal Neoplasm | Ketorolac Acetaminophen Oxycodone Hydromorphone Ibuprofen | 18 Years - 99 Years | University of Miami | |
| The Effect of Esketamine on Patients Undergoing Tumor Surgery | NCT04613869 | Tumor Surgery | High-dose Esket... Low-dose Esketa... Hydromorphone | 18 Years - 65 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain | NCT00766831 | Cancer Pain | Hydromorphone | 20 Years - | Janssen Korea, Ltd., Korea | |
| Synergistic Effect of Ibuprofen and Hydromorphone for Postoperative Pain | NCT02461056 | Breast Cancer | Ibuprofen Hydromorphone | 19 Years - 80 Years | Samsung Medical Center | |
| Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain | NCT04296305 | Hematopoietic a... Malignant Solid... | Hydromorphone Placebo Adminis... Questionnaire A... | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
